The first step is talking with your healthcare provider about anemia before you receive chemotherapy. Also, you can keep track of your hemoglobin levels and let your healthcare provider know how you’re feeling.
If you are seeking general knowledge, support, research updates, or more information on cancer and chemotherapy, try visiting one of the following websites:
A website dedicated to helping patients prepare for treatment with chemotherapy, managing its side effects, and life after chemotherapy.
A website for the Lung Cancer Alliance, a nonprofit organization dedicated to fighting lung cancer in the US, with educational and support resources.
The above list of third-party resources is for your information only. Unless otherwise specified, Amgen does not endorse and is not responsible for the content included in these resources.
Aranesp® is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Aranesp® has not been shown to improve quality of life, fatigue, or patient well-being.
Aranesp® is not indicated for use: